Abstracts tagged "functional status"

Abstract Number: 1093 • 2012 ACR/ARHP Annual Meeting
Obesity Is Not a Risk Factor for Poor Pain and Function Two Years After Total Knee Replacement
Lisa A. Mandl¹, Mark P. Figgie², Alejandro Gonzalez Della Valle³, Michael Alexiades³ and Susan M. Goodman¹, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Orthopedics, Hospital for Special Surgery, New York, NY, ³Orthopaedics, Hospital for Special Surgery, New York, NY
Background/Purpose: Almost 90% of referring physicians think obesity increases the likelihood of poor outcomes after total knee replacement (TKR). However, current data are conflicting. The…
Abstract Number: 917 • 2012 ACR/ARHP Annual Meeting
Feasibility of Remote Activity and Functional Status Monitoring of Patients with Hip or Knee Pain
Pim Jetanalin¹, Hyeon Eui Kim¹, Zia Agha², Nathaniel Heintzman¹, Lucila Ohno-Macado¹ and Susan J. Lee³, ¹University of California, San Diego, La Jolla, CA, ²San Diego Veterans Affairs Medical Center, San Diego, CA, ³University of California San Diego, La Jolla, CA
Background/Purpose: The incidence of total hip and knee arthroplasties has risen over the past decade and by 2030, the demand of these arthroplasties is estimated…
Abstract Number: 2694 • 2012 ACR/ARHP Annual Meeting
Examination of a Multidimensional Model of Disability and Role Functioning in Patients with Rheumatoid Arthritis
Sarah R. Ormseth¹, Taylor Draper², M. Custodio³, Michael H. Weisman⁴, M.R. Irwin⁵ and Perry M. Nicassio⁵, ¹Cousins Center for PNI, University of California, Los Angeles, Los Angeles, CA, ²Psychology, Loma Linda University, Loma Linda, CA, ³UCLA, Los Angeles, CA, ⁴Cedars-Sinai Medical Center, Los Angeles, CA, ⁵Cousins Center for PNI, UCLA, Los Angeles, CA
Background/Purpose: Disability and impairments in role functioning are common obstacles for many patients with RA. A combination of disease-related and psychosocial factors may contribute to…
Abstract Number: 717 • 2012 ACR/ARHP Annual Meeting
Results From a Multi-Tiered Item Collection On Linking Systemic Sclerosis to the International Classification of Functioning, Disability and Health: A EULAR Scleroderma Trials and Research Initiative
Lesley Ann Saketkoo¹, Reuben Escorpizo², Kevin J. Keen³, Kim Fligelstone⁴ and Oliver Distler⁵, ¹LSU Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, ²ICF Research Branch in cooperation with the WHO Collaborating Centre for the Family of International Classifications in Germany (DIMDI), Nottwil, Switzerland, ³Mathematics and Statistics, University of Northern British Columbia, Prince George, BC, Canada, ⁴Royal Free Hospital, Scleroderma Unit and Scleroderma Society, London, United Kingdom, ⁵Department of Rheumatology and Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland
Background/Purpose: Systemic Sclerosis (SSc) affects multiple organs with complex combinations of disability. Skin fibrosis, ischemic pain, ulceration, arthritis, joint contractures, myopathy and cardiopulmonary, renal as…
Abstract Number: 2444 • 2012 ACR/ARHP Annual Meeting
Restricting Back Pain Is Associated with Disability in Community-Living Older Persons
Una E. Makris¹, Liana Fraenkel², Ling Han³, Linda Leo-Summers³ and Thomas M. Gill⁴, ¹Rheumatology, UT Southwestern Medical Center, VA Medical Center, Dallas, TX, ²Medicine, Section of Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT, ³Internal Medicine, Department of Medicine, New Haven, CT, ⁴Internal Medicine, Section of Geriatrics, Yale University, New Haven, CT
Background/Purpose: Although back pain is common and costly, few longitudinal studies have evaluated the association between back pain, severe enough to restrict activity (hereafter referred…
Abstract Number: 403 • 2012 ACR/ARHP Annual Meeting
The Impact of Reaching Low Disease Activity in the First Year On Future Disability and Damage in Patients with Early Rheumatoid Arthritis
Pooneh Akhavan¹, George A. Tomlinson², Paul R. Fortin³ and Claire Bombardier¹, ¹Rheumatology, University of Toronto, Toronto, ON, Canada, ²Dept of Medicine/Rheumatology, Toronto General Hospital, Toronto, ON, Canada, ³Medicine, Centre de Recherche du Chu de Québec et Université Laval, Quebec City, QC, Canada
Background/Purpose: Remission has been proposed as the goal of treatment in patients with early rheumatoid arthritis (RA) by current clinical practice guidelines. Remission is ideal…
Abstract Number: 2445 • 2012 ACR/ARHP Annual Meeting
Ipsilateral Lower Extremity Joint Involvement Increases the Risk of Poor Pain and Function Outcomes After Hip or Knee Arthroplasty
Jasvinder A. Singh¹ and David Lewallen², ¹Department of Medicine, University of Alabama, Tuscaloosa, AL, ²Orthopedics, Mayo Clinic college of medicine, Rochester
Background/Purpose: Persistent pain and functional limitation are unfavorable outcomes after knee and hip replacement, which are getting increasing attention due to a dramatic increase in…
Abstract Number: 360 • 2012 ACR/ARHP Annual Meeting
Initial Introduction of Treat-to-Target Strategy in Patients with Recent Onset Rheumatoid Arthritis Is More Effective Than Delayed Introduction of Strategy with More Clinical and Functional Remission Achieved for 2-Years: Results of the Treating to Twine Targets (T-4) Study
Yukitomo Urata¹, Yoshihide Nakamura² and Ken-ichi Furukawa³, ¹Rheumatology, Seihoku Central Hospital, United Municipalities of Tsugaru, Gosyogawara, Japan, ²Orthopaedic Surgery, Seihoku Central Hospital, United Municipalities of Tsugaru, Gosyogawara, Japan, ³Pharmacology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
Background/Purpose: To compare the clinical, radiological and functional efficacy of initial versus delayed introduction of strategy which is treat-to-target to patients with recent onset rheumatoid…
Abstract Number: 2139 • 2012 ACR/ARHP Annual Meeting
Smoking Is Associated with Worsening Functional Status Over Time in a Diverse Cohort of Patients with Rheumatoid Arthritis
Matthew Reimert¹, Laura Trupin², Patricia P. Katz³, Edward H. Yelin⁴, Jennifer Barton² and John B. Imboden⁵, ¹Rheumatology, University of CA San Francisco, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Medicine, University of California San Francisco, San Francisco, CA, ⁴Medicine, UC San Francisco, San Francisco, CA, ⁵Department of Medicine, Division of Rheumatology, UCSF, San Francisco, CA
Background/Purpose: Although the effects of tobacco use on disease onset, severity, and response to therapy have been well studied in rheumatoid arthritis (RA), there is…
Abstract Number: 219 • 2012 ACR/ARHP Annual Meeting
Significant Functional Improvement Using Aggressive Immunomodulatory Therapy in Patients with Inflammatory Myopathy and Interstitial Lung Disease
Ramona Mihu¹, Roger D. Rossen², Jovan Popovich³ and Sandra L. Sessoms¹, ¹Immunology, Allergy and Rheumatology, Baylor College of Medicine, Houston, TX, ²Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, ³Medicine/Rheumatology, The Methodist Hospital, Houston, TX
Background/Purpose: Pulmonary disease in patients with idiopathic inflammatory myopathies, polymyositis (PM), dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM) is a major cause of morbidity. Approximately…
Abstract Number: 2061 • 2012 ACR/ARHP Annual Meeting
Physician Variation in Documentation of Rheumatoid Arthritis Quality Measures and Evaluation of Relationship with Radiographic Progression
Sonali Desai¹, Jinoos Yazdany², Nancy A. Shadick³, Siri Lillegraven⁴, Chih-Chin Liu⁵, Michelle A. Frits⁶, Tabatha Norton⁷, Jonathan S. Coblyn⁸, Michael Weinblatt⁵ and Daniel H. Solomon⁹, ¹Medicine/ Rheumatology, Boston, MA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA, ⁴Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁵Rheumatology & Immunology, Brigham & Women's Hospital, Boston, MA, ⁶Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁷Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁸Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁹Division of Rheumatology, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Documentation of quality measures (QMs) in rheumatoid arthritis (RA) has been proposed as a way to demonstrate quality of care, but data linking appropriate…
Abstract Number: 95 • 2012 ACR/ARHP Annual Meeting
Smoking Is Associated with Worse and More Widespread Pain, Worse Disease Activity, Function, Fatigue and Health Related Quality of Life in Patients with Axial Spondyloarthritis –Results From a Population Based Cohort
Ann B. I. Bremander¹, Ingemar F. Petersson², Emma Haglund³, Stefan Bergman⁴ and Lennart TH Jacobsson⁵, ¹Department of Exercise Physiology, Biomechanics and Health, Halmstad University School of Business and Engineering, Halmstad, Sweden, ²Lund University, Lund, Sweden, ³Research and Development Centre, Spenshult Hospital for Rheumatic Diseases, Halmstad, Sweden, ⁴Spenshult Research and Development Center, Halmstad, Sweden, ⁵Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Background/Purpose: In subjects with early axial Spondyloarthritis (SpA) smoking has recently been associated with earlier onset of disease, worse lesions of the sacroiliac joints and…
Abstract Number: 1867 • 2012 ACR/ARHP Annual Meeting
Assessment of ART Therapy Program for Women with Fibromyalgia: Randomized, Controlled, Blinded Study
Andreia S. Baptista¹, Anamaria Jones¹, Fernanda P. Cardoso¹, Betina C. Schaffir¹, Elisa R. W. Coelho¹, Aline Orlandi¹ and Jamil Natour², ¹Unifesp-EPM, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, ²Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil
Background/Purpose: Fibromyalgia (FM) is a chronic non-inflammatory syndrome characterized by diffuse pain throughout the body, sleep disorder, stiffness, fatigue, depression and other psychological problems. Patients…
Abstract Number: 1828 • 2012 ACR/ARHP Annual Meeting
Smoking Is Associated with Worse and More Widespread Pain, Worse Fatigue, General Health and Quality of Life in a Swedish Population Based Cohort of Patients with Psoriatic Arthritis
Ann B. I. Bremander¹, Lennart TH Jacobsson², Stefan Bergman³, Emma Haglund⁴ and Ingemar F. Petersson⁵, ¹Department of Exercise Physiology, Biomechanics and Health, Halmstad University School of Business and Engineering, Halmstad, Sweden, ²Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, ³Spenshult Research and Development Center, Halmstad, Sweden, ⁴Research and Development Centre, Spenshult Hospital for Rheumatic Diseases, Halmstad, Sweden, ⁵Lund University, Lund, Sweden
Background/Purpose: Smoking has been found to be associated with an increased risk of developing psoriatic arthritis (PsA). The purpose of this study was analyse possible…
Abstract Number: 1831 • 2012 ACR/ARHP Annual Meeting
Evaluation of the Cost-Effectiveness of Rheumatoid Arthritis Treatment with Biologic Agents Using the IORRA Cohort Database
Eiichi Tanaka¹, Eisuke Inoue², Daisuke Hoshi³, Akiko Kobayashi², Naoki Sugimoto², Kumi Shidara², Eri Sato³, Yasushi Inoue³, Yohei Seto², Ayako Nakajima⁴, Shigeki Momohara³, Atsuo Taniguchi² and Hisashi Yamanaka³, ¹Tokyo Women's Medical University, Tokyo, Japan, ²Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, ³Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ⁴Rheumatology, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Background/Purpose: Rheumatoid arthritis (RA), a chronic inflammatory disorder, causes a significant decrease in quality of life. Recently developed biologic agents (BAs) have caused a considerable…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].